PBM
Price
$0.60
Change
+$0.01 (+1.69%)
Updated
Apr 3, 04:54 PM (EDT)
Capitalization
2.63M
SLRX
Price
$0.74
Change
+$0.01 (+1.37%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
1.28M
Ad is loading...

PBM vs SLRX

Header iconPBM vs SLRX Comparison
Open Charts PBM vs SLRXBanner chart's image
Psyence Biomedical
Price$0.60
Change+$0.01 (+1.69%)
Volume$654
Capitalization2.63M
Salarius Pharmaceuticals
Price$0.74
Change+$0.01 (+1.37%)
Volume$150
Capitalization1.28M
PBM vs SLRX Comparison Chart
Loading...
PBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PBM vs. SLRX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBM is a Buy and SLRX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (PBM: $0.58 vs. SLRX: $0.74)
Brand notoriety: PBM and SLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PBM: 20% vs. SLRX: 20%
Market capitalization -- PBM: $2.63M vs. SLRX: $1.28M
PBM [@Biotechnology] is valued at $2.63M. SLRX’s [@Biotechnology] market capitalization is $1.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBM’s FA Score shows that 1 FA rating(s) are green whileSLRX’s FA Score has 1 green FA rating(s).

  • PBM’s FA Score: 1 green, 4 red.
  • SLRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both PBM and SLRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBM’s TA Score shows that 5 TA indicator(s) are bullish while SLRX’s TA Score has 5 bullish TA indicator(s).

  • PBM’s TA Score: 5 bullish, 3 bearish.
  • SLRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both PBM and SLRX are a good buy in the short-term.

Price Growth

PBM (@Biotechnology) experienced а -11.30% price change this week, while SLRX (@Biotechnology) price change was -19.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

PBM is expected to report earnings on Mar 23, 2023.

SLRX is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBM($2.63M) has a higher market cap than SLRX($1.28M). SLRX YTD gains are higher at: -59.620 vs. PBM (-72.464). SLRX has higher annual earnings (EBITDA): -5.21M vs. PBM (-51.11M). SLRX has more cash in the bank: 3.28M vs. PBM (598K). SLRX has less debt than PBM: SLRX (329K) vs PBM (733K). PBM (0) and SLRX (0) have equivalent revenues.
PBMSLRXPBM / SLRX
Capitalization2.63M1.28M205%
EBITDA-51.11M-5.21M981%
Gain YTD-72.464-59.620122%
P/E RatioN/AN/A-
Revenue00-
Total Cash598K3.28M18%
Total Debt733K329K223%
FUNDAMENTALS RATINGS
SLRX: Fundamental Ratings
SLRX
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PBMSLRX
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
86%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
PBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCGIX30.28N/A
N/A
Goldman Sachs Large Cap Gr Insghts Instl
LEGCX44.64N/A
N/A
Columbia Large Cap Growth C
OTCRX14.20N/A
N/A
Otter Creek Long/Short Opportunity Inv
LHCIX18.06N/A
N/A
Lord Abbett Health Care I
RGPAX20.29N/A
N/A
RBC Global Opportunities A

PBM and

Correlation & Price change

A.I.dvisor tells us that PBM and ATHA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PBM and ATHA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBM
1D Price
Change %
PBM100%
-1.29%
ATHA - PBM
31%
Poorly correlated
-7.47%
SLRX - PBM
30%
Poorly correlated
+2.27%
PRME - PBM
26%
Poorly correlated
-10.06%
PRTA - PBM
26%
Poorly correlated
-6.75%
NTLA - PBM
26%
Poorly correlated
-5.75%
More

SLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRX has been closely correlated with MBIO. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if SLRX jumps, then MBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRX
1D Price
Change %
SLRX100%
+2.27%
MBIO - SLRX
71%
Closely correlated
-9.72%
PHIO - SLRX
43%
Loosely correlated
-4.13%
AZTR - SLRX
40%
Loosely correlated
-1.48%
NRSN - SLRX
32%
Poorly correlated
+3.14%
PBM - SLRX
30%
Poorly correlated
-1.29%
More